Medical News

RSS

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

More than 100 women per day die from breast cancer in the United States. The odds of developing breast cancer increase for women taking hormone replacement therapy to avoid the effects of menopause.

28 Mar 2013

USAID has played vital role in global efforts to end preventable child deaths

Noting USAID last week "released its first progress report examining how reforms enacted three years ago have strengthened the agency's relentless focus on results," Nicole Schiegg, a senior adviser at the agency, writes in the GlobalPost's "Global Pulse" blog, "One of the strongest examples of leveraging innovation and partnership is USAID's contribution to ending preventable child deaths."

28 Mar 2013

Stress during pregnancy increases risk of stillbirth, say researchers

Pregnant women who experienced financial, emotional, or other personal stress in the year before their delivery had an increased chance of having a stillbirth, say researchers who conducted a National Institutes of Health network study.

28 Mar 2013

Study indicates link between estrogen and body fat storage

Women tend to carry excess fat in their hips and thighs, while men tend to carry it on their stomachs. But after menopause, things start to change: many women's fat storage patterns start to resemble those of men.

28 Mar 2013

New screening procedure determines animal, plant, and microbial substances in foodstuffs

Scientists at the Institute of Molecular Genetics, Genetic Security Research and Consulting at Johannes Gutenberg University Mainz (JGU) have developed a novel screening procedure that provides for highly sensitive, quantifiable analysis of animal, plant, and microbial substances present in foodstuffs.

28 Mar 2013

Stronger protections needed to prevent hepatitis in HIV patients

Stronger protections are needed to prevent people with HIV from also becoming infected with hepatitis, researchers argue in a new study led by Michigan State University.

28 Mar 2013

Study: New genetic variants may increase cancer risk

The European Collaborative Oncological Gen-Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes today a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.

28 Mar 2013

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.

28 Mar 2013

Chromatrap chromatin immunoprecipitation (ChIP) assay range added to Porvair Sciences’ portfolio of products for epigenetics

Porvair Sciences has announced the addition of the novel Chromatrap chromatin immunoprecipitation (ChIP) assay range to its portfolio of products for epigenetics.

From Chromatrap® - Porvair Sciences Ltd 28 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

Phase 2 study of REOLYSIN meets primary endpoint in patients with squamous cell lung cancer

Oncolytics Biotech Inc. today announced that it has met the primary overall statistical endpoint in its U.S. Phase 2 single arm clinical trial in patients with squamous cell carcinoma of the lung using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel in patients with metastatic stage IIIB, or stage IV, or recurrent SCCLC who are chemotherapy naïve for their metastatic or recurrent cancer (REO 021).

28 Mar 2013

Viewpoints: Calif. insurers ignore Commissioner on premiums; Rick Perry says 'broken' Medicaid can't handle expansion; Doctor says NRA let him down

While most of us face uncertainty with the rollout of healthcare reform, some insurance companies in California have been feeling their oats lately. Here's how they're responding to Insurance Commissioner Dave Jones' warnings that their latest rate increases are unreasonable: Stuff it, Dave.

28 Mar 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

28 Mar 2013

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

Prostate cancer is the most common cancer in men. Despite many advances in diagnosis and treatment over the past two decades, it remains the second most common cause of cancer related death in men.

28 Mar 2013

Britain launches plan to fight use of rape as weapon of war in DRC

On a trip to Goma, "in the violent south-eastern corner of the Democratic Republic of the Congo [DRC]," British Foreign Secretary William Hague launched the U.K.'s plan to help tackle rape as a weapon of war, "announcing £180 million [$272 million] in new funding for the DRC health system, some of which will go to training medical staff to give proper care for rape victims," The Guardian reports.

28 Mar 2013

Pinnaclemed purchases Mazor Robotics' Renaissance system

Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, today announced that Pinnaclemed Co., Ltd., the Company's distribution partner in Taiwan, purchased its first Renaissance system.

28 Mar 2013

Blog reports on Annual World Water Day Congressional Advocacy Day on Capitol Hill

"On March 20, 2013, the Global Network for Neglected Tropical Diseases participated in the 4th Annual World Water Day Congressional Advocacy Day on Capitol Hill in Washington, D.C.," the organization's "End the Neglect" blog reports.

28 Mar 2013

Data shows efficacy of MANF in neuroprotection 6-hydroxydopamine rat models of Parkinson's disease

Amarantus BioScience, Inc., a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today reported positive preclinical data for its lead therapeutic MANF in neuroprotection 6-hydroxydopamine (6-OHDA) rat models of Parkinson's disease.

28 Mar 2013

Researchers uncover DNA rearrangement process for sex determination in Tetrahymena

It's been more than 50 years since scientists discovered that the single-celled organism Tetrahymena thermophila has seven sexes. But in all that time, they've never known how each cell's sex, or "mating type," is determined.

28 Mar 2013

SNSF-supported study on child development

On average, children take the first steps on their own at the age of 12 months. Many parents perceive this event as a decisive turning point. However, the timing is really of no consequence. Children who start walking early turn out later to be neither more intelligent nor more well-coordinated.

28 Mar 2013

Medical News

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

USAID has played vital role in global efforts to end preventable child deaths

Stress during pregnancy increases risk of stillbirth, say researchers

Study indicates link between estrogen and body fat storage

New screening procedure determines animal, plant, and microbial substances in foodstuffs

Stronger protections needed to prevent hepatitis in HIV patients

Study: New genetic variants may increase cancer risk

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Chromatrap chromatin immunoprecipitation (ChIP) assay range added to Porvair Sciences’ portfolio of products for epigenetics

First Edition: March 28, 2013

Phase 2 study of REOLYSIN meets primary endpoint in patients with squamous cell lung cancer

Viewpoints: Calif. insurers ignore Commissioner on premiums; Rick Perry says 'broken' Medicaid can't handle expansion; Doctor says NRA let him down

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

Britain launches plan to fight use of rape as weapon of war in DRC

Pinnaclemed purchases Mazor Robotics' Renaissance system

Blog reports on Annual World Water Day Congressional Advocacy Day on Capitol Hill

Data shows efficacy of MANF in neuroprotection 6-hydroxydopamine rat models of Parkinson's disease

Researchers uncover DNA rearrangement process for sex determination in Tetrahymena

SNSF-supported study on child development

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News